Pulmonary Disease, Chronic Obstructive  >>  AZD5423  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD5423 / AstraZeneca
NCT01555099 / 2011-005389-39: Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

Completed
2
353
Europe, RoW
AZD5423, Budesonide, Placebo
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
04/13
04/13

Download Options